MedTrace Logo

An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure

NCT05140759 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2024-01-19

No results posted yet for this study

Summary

This study will assess the functionality and tolerability of an automated continual water removal system in up to 8 patients with HF and diuretic resistance.

intervention: Implanted absorption chamber, connected to an external pump. Follow up: 3 months post activation.

Conditions

Interventions

DEVICE

automated continual water removal system

The device removes excess fluids in heart failure patients with diuretic resistance

Sponsors & Collaborators

  • Paragate Medical LTD

    lead INDUSTRY

Principal Investigators

  • Aharon Abbo, MD · Rambam Health Care Campus

  • Robert Zymlinski, MD · Uniwersytecki Szpital Kliniczny im Jana Mikulicza-Radeckiego, ul. Borowska 213, 50-556 Wrocław

  • Paata Meshveliani, MD · West Georgian Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-24
Primary Completion
2024-01-17
Completion
2024-01-17

Countries

  • Georgia
  • Israel
  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05140759 on ClinicalTrials.gov